These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


271 related items for PubMed ID: 10373066

  • 1. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study.
    Nagler RM, Nagler A.
    Bone Marrow Transplant; 1999 May; 23(10):1007-11. PubMed ID: 10373066
    [Abstract] [Full Text] [Related]

  • 2. Effect of pilocarpine hydrochloride on unstimulated whole saliva flow rate and composition in patients with chronic graft-versus-host disease (cGVHD).
    Agha-Hosseini F, Mirzaii-Dizgah I, Ghavamzadeh L, Ghavamzadeh A, Tohidast-Acrad Z.
    Bone Marrow Transplant; 2007 Apr; 39(7):431-4. PubMed ID: 17310130
    [Abstract] [Full Text] [Related]

  • 3. Parotid salivary gland dysfunction in chronic graft-versus-host disease (cGVHD): a longitudinal study in a mouse model.
    Levy S, Nagler A, Okon S, Marmary Y.
    Bone Marrow Transplant; 2000 May; 25(10):1073-8. PubMed ID: 10828868
    [Abstract] [Full Text] [Related]

  • 4. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia).
    Fox PC, Atkinson JC, Macynski AA, Wolff A, Kung DS, Valdez IH, Jackson W, Delapenha RA, Shiroky J, Baum BJ.
    Arch Intern Med; 1991 Jun; 151(6):1149-52. PubMed ID: 2043017
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
    Omori Y, Asari T, Maruyama K, Kusama H, Kojima M, Shibata N.
    Arzneimittelforschung; 2003 Jun; 53(5):342-50. PubMed ID: 12854361
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):14-22. PubMed ID: 17869018
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oral pilocarpine hydrochloride for the treatment of refractory xerostomia associated with chronic graft-versus-host disease.
    Singhal S, Mehta J, Rattenbury H, Treleaven J, Powles R.
    Blood; 1995 Feb 15; 85(4):1147-8. PubMed ID: 7849306
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD).
    Nagler R, Marmary Y, Krausz Y, Chisin R, Markitziu A, Nagler A.
    Bone Marrow Transplant; 1996 Feb 15; 17(2):219-24. PubMed ID: 8640170
    [Abstract] [Full Text] [Related]

  • 19. Salivary gland involvement in graft-versus-host disease: the underlying mechanism and implicated treatment.
    Nagler RM, Nagler A.
    Isr Med Assoc J; 2004 Mar 15; 6(3):167-72. PubMed ID: 15055275
    [Abstract] [Full Text] [Related]

  • 20. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB, Scrimger RA, Anderson SG, Kurien EC, Thompson HK, Field GC, Hanson J.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):663-73. PubMed ID: 14967418
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.